AC
CNTB

AlphaCore Capital’s Connect Biopharma Holdings CNTB Stock Holding History

AlphaCore Capital’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-80,000
Closed -$78.4K – 1093
2025
Q2 		$78.4K Buy
+80,000
New +$63.8K ﹤0.01% 753

Other funds holding CNTB

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
KWM
Koa Wealth Management Encinitas, California $147M AUM 18.41% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MWA
Monograph Wealth Advisors Manhattan Beach, California $1.05B AUM 23.2% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

AlphaCore Capital's CNTB Position: Q3 2025 in Review

AlphaCore Capital sold out of Connect Biopharma Holdings (CNTB) in Q3 2025, closing a stake of 80,000 shares — an estimated $78.4K sold.

AlphaCore Capital first reported a position in CNTB in Q2 2025 and held it in 1 quarter. The position peaked at $78.4K in Q2 2025. 16 funds tracked by Wall St. Rank hold CNTB as of Q3 2025.

  • AlphaCore Capital reported no remaining Connect Biopharma Holdings position as of Q3 2025 after selling out during the quarter.
  • AlphaCore Capital sold 80,000 Connect Biopharma Holdings shares in Q3 2025, an estimated $78.4K.
  • AlphaCore Capital first reported a position in Connect Biopharma Holdings in Q2 2025 and held it in 1 quarter.
  • AlphaCore Capital's Connect Biopharma Holdings position peaked at $78.4K in Q2 2025.
  • 16 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q3 2025.

Based on AlphaCore Capital's 13F filing for Q3 2025, filed 12 Nov 2025.